Sort
39,280 grants matching “leukemia”
NCTN Deep South Research Consortium
$482,879Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2019 · CA
Correlative Studies of erbB-2/HER2 and p53 in CALGB Pro.
$482,857University Of Michigan At Ann Arbor · R01 · FY2003 · CA
Prevent IgM MGUS Progression by Targeting the Driver Mutation
$482,787Xinfang Yu · Baylor College Of Medicine · U54 · FY2023 · CA
Immunotherapy of low grade lymphoid malignancies
$482,780Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
GENETIC ANALYSIS OF ZEBRAFISH EMBRYO DEVELOPMENT
$482,683Pu Paul Liu · National Human Genome Research Institute · ZIA · FY2009 · HG
ALDH Activation to treat Fanconi Anemia
$482,616Kenneth I. Weinberg · Stanford University · R01 · FY2021 · HL
The function of PLZF in innate T cells
$482,565Derek B. Sant'angelo · Rbhs-Robert Wood Johnson Medical School · R01 · FY2014 · AI
NCTN Deep South Research Consortium
$482,539Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2023 · CA
Epigenetic control of hematopoietic stem cells
$482,500Christa E. Muller-Sieburg · Sidney Kimmel Cancer Center · R56 · FY2007 · DK
Severe Chronic Neutropenia International Registry
$482,494David Chandler Dale · University Of Washington · R24 · FY2008 · AI
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN
$482,420William E. Evans · St. Jude Children'S Research Hospital · R01 · FY2006 · CA
NCTN Deep South Research Consortium
$482,362Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2022 · CA
Spermatogonial Stem Cell Self-Renewal and Differentiation
$482,310Robert E Braun · University Of Washington · U54 · FY2011 · HD
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors
$482,211David W Russell · University Of Washington · R01 · FY2012 · HL
Cyclin Dependent Kinases as Epigenetic Therapy Targets
$482,163Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2021 · CA
Selectively Targeting Oncogenic NRAS in Cancer
$482,100Kevin M Shannon · University Of California, San Francisco · R01 · FY2019 · CA
Elucidating the Functional and Mechanistic Roles of LINE-1 Retrotransposons in Myeloid Leukemia
$482,075Jian Xu · St. Jude Children'S Research Hospital · R01 · FY2025 · CA
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
$482,064Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Investigating the mechanism of SHP2 and BCL2 Inhibition in Acute Myeloid Leukemia (AML)
$482,061Catherine Choy Smith · University Of California, San Francisco · R01 · FY2024 · CA
The biochemical, topological and functional impact of cancer associated Ctcf mutations and their contribution to cancer
$481,945Jane Amanda Skok · New York University School Of Medicine · R01 · FY2018 · CA
Cellular Transduction with Replication-Competent Retrovirus Vectors
$481,936Noriyuki Kasahara · University Of California Los Angeles · R01 · FY2009 · CA
Development of VN/14-1 and Related Analogs for Breast Cancer Therapy
$481,921Vincent Collins Ofuka Njar · University Of Maryland Baltimore · R01 · FY2014 · CA
New Gene Regulatory Proteins Regulating Erythroid Development
$481,850Harvey F Lodish · Boston Children'S Hospital · P01 · FY2012 · HL
Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-cell Acute Lymphoblastic Leukemia
$481,818Matthew Witkowski · University Of Colorado Denver · R37 · FY2025 · CA
Characterizing noncoding GWAS variants in acute lymphoblastic leukemia treatment outcome
$481,751Daniel Savic · St. Jude Children'S Research Hospital · R01 · FY2022 · CA